Objective? [RSABE / ABEL]

posted by jag009  – NJ, 2013-09-16 19:24 (4258 d 10:11 ago) – Posting: # 11500
Views: 7,822

Hi Helmut,

❝ counter-questions: What are you trying to achieve? Why do you think such a design would have advantages over RTRT|TRTR?


Can I answer? :-) (Love to do this when i was in school, jumping to answer first hehe)

I don't like AABB, BBAA, ABBA, BAAB because of giving the same treatment (A
or B) in consecutive period. I have no choice with FDA's partial rep - ABB, BBA, ABA...

John

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
123 visitors (0 registered, 123 guests [including 13 identified bots]).
Forum time: 05:36 CEST (Europe/Vienna)

Don’t undertake a project
unless it’s manifestly important
and nearly impossible.    Edwin H. Land

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5